title: [Adalimumab in Crohn's disease - data from real life].
authors.forename: A
authors.initials: A
authors.lastname: López San Román
authors.forename: M
authors.initials: M
authors.lastname: Van Domselaar
authors.forename: E
authors.initials: E
authors.lastname: Garrido
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab